Abstract
Introduction: Precision medicine describes the customization of healthcare tailored to the individual patient. Generally, vaccines are considered as public health tools rather than from the individual patient perspective. However, adult vaccination programs in particular should consider many different factors, at the individual level and also from societal, cultural and country-specific perspectives. Currently, most immunization programs, including those for pneumococcal vaccines, have only been adopted on the basis of age or medical risk. Areas covered: Based on a broad literature search, this review addresses possible environmental factors which can affect the burden of pneumococcal disease and the immune response to pneumococcal vaccines. Expert opinion: Factors which influence the incidence of pneumococcal disease and the reaction against pneumococcal vaccination, including personal conditions, geographic/ethnic factors and social risks, are diverse. To maximize the effects of pneumococcal vaccination, not only for public health but also to induce optimal effects at the individual level, vaccines need to be verified under diverse situations and with collaboration among relevant medical societies, governments, and the pharmaceutical industry. Whereas vaccines are generally considered only from the public health perspective, flexible, comprehensive and tailored pneumococcal immunization programs, with appropriate policy support, can generate a greater positive impact on public health.
Original language | English |
---|---|
Pages (from-to) | 587-596 |
Number of pages | 10 |
Journal | Expert Review of Vaccines |
Volume | 18 |
Issue number | 6 |
DOIs | |
Publication status | Published - 2019 Jun 3 |
Bibliographical note
Funding Information:Under the direction of the authors, medical writing assistance was provided by David P. Figgitt, ISMPP CMPP™, Content Ed Net, with funding from Pfizer Pharmaceuticals Korea Ltd., Seoul, Republic of Korea.
Publisher Copyright:
© 2019, © 2019 Informa UK Limited, trading as Taylor & Francis Group.
Keywords
- Environmental factors
- PCV13
- PPSV23
- pneumococcal vaccine
- pneumovax
- prevnar
ASJC Scopus subject areas
- Immunology
- Molecular Medicine
- Pharmacology
- Drug Discovery